Table 39 (abstract P352). See text for description
From: Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two
6 months | 12 months | 24 months | ||||
|---|---|---|---|---|---|---|
GOSH (n = 88) | IGG (n = 36) | GOSH (n = 81) | IGG (n = 35) | GOSH (n = 71) | IGG (n = 34) | |
MMT-8 = 80 | 22/75 (29.3) | 9/30 (30) | 32/75 (42.7) | 16/32 (50) | 37/67 (55.2) | 24/33 (72.7) |
CMAS = 52 | 25/81 (30.9) | 6/21 (28.6) | 28/70 (40) | 10/20 (50) | 40/71 (56.3) | 14/17 (82.3) |
DAS = 0 | 15/86 (17.4) | 6/32 (18.7) | 24/74 (32.4) | 10/34 (29.4) | 40/71 (56.3) | 17/29 (58.6) |
MD global = 0 | 13/60 (21.7) | 4/18 (22.2) | 18/59 (30.5) | 8/19 (42.1) | 37/62 (59.7) | 16/22 (72.7) |
Normal physical function | 21/59 (35.6) | 8/13 (61.5) | 28/64 (43.7) | 9/10 (90) | 36/59 (61) | 14/17 (82.3) |
MDI = 0 | 72/84 (85.7) | 26/28 (92.9) | 64/74 (86.5) | 24/28 (85.7) | 61/70 (87) | 20/22 (90.9) |
Inactive disease | 13/86 (15.2) | 11/35 (31.4) | 28/74 (37.8) | 17/33 (51.5) | 51/70 (72.9) | 23/30 (76.7) |